{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.197","meta":{"versionId":"6","lastUpdated":"2021-05-21T01:00:57.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.197","version":"20210521","name":"Doxorubicin Pegylated Liposomal Injectable","status":"active","date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1790115","display":"10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"},{"code":"1790127","display":"25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:2a43e5a2-f071-49ee-ba4e-4793f64d5988","timestamp":"2022-06-10T07:11:37-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1790115","display":"10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1790127","display":"25 ML doxorubicin hydrochloride liposome 2 MG/ML Injection"}]}}